Cost-Utility Analysis of Primary Prophylaxis versus Treatment On-Demand for Individuals with Severe Haemophilia

Author： Miners A.H.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.11, 2002-01, pp. : 759-774

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary prophylaxis cost effective in severe haemophilia?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 379, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Primary prophylaxis cost effective in severe haemophilia?

By  

Inpharma, Vol. 1, Iss. 1354, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy

By Anis Aslam H.   Sun Huiying  

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 387-400

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Methadone Maintenance Treatment: A Methodological Approach

By Vanagas Giedrius   Padaiga Zilvinas   Bagdonas Eugenijus  

Substance Use & Misuse, Vol. 41, Iss. 1, 2006-06 ,pp. : 87-101

Informa Healthcare

Access to resources Recommend Favorite

Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B

By Dakin Helen   Bentley Anthony   Dusheiko Geoff  

Value in Health, Vol. 13, Iss. 8, 2010-12 ,pp. : 922-933

Blackwell Publishing

Access to resources Recommend Favorite